Chemical Structure : Tegoprazan
CAS No.: 942195-55-3
Catalog No.: PC-60811Not For Human Use, Lab Use Only.
Tegoprazan (CJ 12420, RQ-00000004, RQ-4) is a novel potent, highly selective, competitive and orally active inhibitor of gastric H+/K+-ATPase with IC50 of ranging 0.29-0.52 uM porcine, canine and human H+/K+-ATPases in vitro.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $118 | In stock | |
10 mg | $178 | In stock | |
25 mg | $298 | In stock | |
50 mg | $488 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tegoprazan (CJ 12420, RQ-00000004, RQ-4) is a novel potent, highly selective, competitive and orally active inhibitor of gastric H+/K+-ATPase with IC50 of ranging 0.29-0.52 uM porcine, canine and human H+/K+-ATPases in vitro.
Tegoprazan displays no activity against canine kidney Na+/K+-ATPase (IC50>100 uM).
Tegoprazan potently inhibits histamine-induced gastric acid secretion in dogs and a complete inhibition at 1.0 mg/kg starting from 1 hr after administration, reverses the pentagastrin-induced acidified gastric pH to the neutral range at 1-3 mg/kg, immediately evoks a gastric phase III contraction of migrating motor complex (MMC) in pentagastrin-treated dogs.
M.Wt | 387.387 | |
Formula | C20H19F2N3O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(S)-4-((5,7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide |
1. Takahashi N, et al. J Pharmacol Exp Ther. 2017 Nov 27. pii: jpet.117.244202.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright